Progress in treatment and misdiagnosis of primary biliary cirrhosis
[1]James OFW, Bhopal R, Howel D, et al.Primary biliary cirrhosisonce rare, now common in the united kingdom[J].Hepatology, 1999, 30 (2) ∶390-394.
|
[2]Heathcote EJ.Management of primary biliary cirrhosis.The Americanassociation for the study of liver diseases practice guide-lines[J].Hepatology, 2000, 31 (4) ∶1005-1013.
|
[3]罗红春, 梅浙川.原发性胆汁性肝硬化的治疗进展[J].国际消化病杂志, 2008, 28 (1) ∶60-62.
|
[4]王宝恩.重视原发性胆汁性肝硬化的研究[J].肝脏, 2002, 7 (3) ∶145-147.
|
[5]姚光弼.中国人原发性胆汁性肝硬化的前瞻性研究[J].肝脏, 2002, 7 (3) ∶146-148.
|
[6]Oo YH, Neuberger J.Options for t reatment of primary biliary cir-rhosis[J].Drugs, 2004, 64 (20) ∶2261-2271.
|
[7]Kolidinger R.Treatment of primary biliary cirrhosis withcolchicines[J].Gastroenterology, 1980, 78 (5) ∶1309-1311.
|
[8]Akbar SM, Furukawa S, Nakanishi S, et al.Therapeutic efficacy ofdecreased nit rite production by bezafibrate in patients with primarybiliary cirrhosis[J].Gastroenterology, 2005, 40 (2) ∶157-163.
|
[9]Kanda T, Yokosuka O, Imazeki F, et al.Bezafibrate treatment:anew medical approach for PBC patients[J].Gastroenterology, 2003, 38 (6) ∶573-578.
|
[10]Angulo P, Dickson ER.The timing of liver transplantation in pri-mary biliary cirrhosis[J].Baillieres Best Pract Res Clin Gastroen-terol, 2000, 14 (4) ∶657-668.
|
[11]初玉琳, 刘双燕, 王秀娟.原发性胆汁性肝硬化的诊治教训[J].中国民康医学, 2007, 19 (8) ∶306-308.
|
[12]Tsuji K, Watanabe Y, Van de water J, et al.Familial primary biliarycirrhosis in Hiroshima[J].Autoimmuinity, 1999, 13 (1) ∶171-178.
|
[13]Jones DEJ, Watt FE, Metcalf V, et al.Familial primary biliary cir-rhosis reassessed:a geographically-based population study[J].Hepatol, 1999, 30 (3) ∶402-407.
|
[1] | Huang ChunYang, Liu YanMin. Prognostic evaluation of primary biliary cirrhosis and its value in guiding therapeutic regimens[J]. Journal of Clinical Hepatology, 2016, 32(7): 1266-1272. doi: 10.3969/j.issn.1001-5256.2016.07.009 |
[2] | Ning HuiMing, Ou Qiang. Research advances in diagnosis and treatment of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(4): 802-805. doi: 10.3969/j.issn.1001-5256.2016.04.045 |
[3] | Wang Sui, Wang JiangBin. The diagnosis and treatment of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1605-1607. doi: 10.3969/j.issn.1001-5256.2015.10.010 |
[4] | Chen BiHua, Zhang Wei, Wu Pei, Huang Ying. Research advances in risk factors for primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(12): 2088-2092. doi: 10.3969/j.issn.1001-5256.2015.12.024 |
[5] | Li XiaoShu, Ceng Hui, Wang XianBo. Research progress in immunological mechanisms for primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(8): 1365-1369. doi: 10.3969/j.issn.1001-5256.2015.08.048 |
[6] | Zhu JiangYi, Han Ying. Research advances in primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 163-164. doi: 10.3969/j.issn.1001-5256.2015.02.004 |
[7] | Yu Yuan, Yang ZongGuo, Chen ChiChi, Lu YunFei, Xu QingNian, Chen XiaoRong. Efficacy of adjuvant therapy with fenofibrate for primary biliary cirrhosis: a Meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1630-1633. doi: 10.3969/j.issn.1001-5256.2015.10.017 |
[8] | Wang Qian, Yao DingKang. Research progress in medical treatment of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(5): 462-465. doi: 10.3969/j.issn.1001-5256.2014.05.022 |
[9] | Lu WeiTing, Jiang XingHuo, Guo HaiYan, Zhao JianXue. Clinical features of primary biliary cirrhosis: a clinical analysis of 70 cases[J]. Journal of Clinical Hepatology, 2013, 29(12): 926-928. doi: 10.3969/j.issn.1001-5256.2013.12.013 |
[10] | Qin Hua, Bai ShiShan. Advances in treatment of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(9): 719-721. doi: 10.3969/j.issn.1001-5256.2013.09.023 |
[11] | Zhang Li, Bai ShiShan. Research progress on laboratory diagnosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1109-1111+1120. |
[12] | Duan WeiJia, You Hong. Therapy advances in primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(6): 581-583. |
[14] | Gao Feng, Zhang FuKui, Jia JiDong. Liver function changes of ursodeoxycholic acid made in china for patients with primary biliary cirrhosis.[J]. Journal of Clinical Hepatology, 2008, 24(4): 278-280. |
[19] | He WenTao, Shi JianShi. Clinical analysis of primary bilary cirrhosis.[J]. Journal of Clinical Hepatology, 2001, 17(3): 180-181. |